Inventor
GENESTE HERVÉ
DE20 patents
⚠️ This page may combine multiple inventors who share the name “GENESTE HERVÉ”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBVIE DEUTSCHLAND
17 patentsUS9527856B2Dec 27, 2016
Oxindole compounds carrying a CO-bound spiro substituent and use thereof for treating vasopressin-related diseases
ABBVIE DEUTSCHLAND4 citations70
US9790203B2Oct 17, 2017
Inhibitor compounds of phosphodiesterase type 10A
ABBVIE DEUTSCHLAND2 citations62
US9200005B2Dec 1, 2015
Inhibitor compounds of phosphodiesterase type 10A
ABBVIE DEUTSCHLAND3 citations60
US9422264B2Aug 23, 2016
Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases
ABBVIE DEUTSCHLAND1 citations52
US9403796B2Aug 2, 2016
Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
ABBVIE DEUTSCHLAND0 citations52
US10308610B2Jun 4, 2019
Inhibitor compounds of phosphodiesterase type 10A
ABBVIE DEUTSCHLAND0 citations51
US9856220B2Jan 2, 2018
Inhibitor compounds of phosphodiesterase type 10A
ABBVIE DEUTSCHLAND1 citations51
US9487505B2Nov 8, 2016
Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
ABBVIE DEUTSCHLAND1 citations51
US9475808B2Oct 25, 2016
Inhibitor compounds of phosphodiesterase type 10A
ABBVIE DEUTSCHLAND1 citations51
US9163019B2Oct 20, 2015
Inhibitor compounds of phosphodiesterase type 10A
ABBVIE DEUTSCHLAND1 citations51
US9657034B2May 23, 2017
Substituted furo[3,2-c]pyridines, thieno[3,2-c]pyridines, thieno[2,3-d]pyridazines and pyrido[3,4-d]pyridazines as phosphodiesterase type 10A inhibitors
ABBVIE DEUTSCHLAND0 citations50
US10160744B2Dec 25, 2018
Quinoline compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor
ABBVIE DEUTSCHLAND0 citations41
US9688678B2Jun 27, 2017
Oxindole compounds carrying a nitrogen-bound spiro substituent and use thereof for treating vasopressin-related diseases
ABBVIE DEUTSCHLAND0 citations41
US9464085B2Oct 11, 2016
Inhibitor compounds of phosphodiesterase type 10A
ABBVIE DEUTSCHLAND0 citations41
US9862704B2Jan 9, 2018
Oxindole derivatives carrying an amine-substituted piperidyl-acetidinyl substituent and use thereof for treating vasopressine-related diseases
ABBVIE DEUTSCHLAND0 citations40
US9840495B2Dec 12, 2017
Oxindole derivatives carrying a piperidyl-substituted azetidinyl substituent and use thereof for treating vasopressine-related diseases
ABBVIE DEUTSCHLAND0 citations40
US9617226B2Apr 11, 2017
Fused heterocyclic or carbocyclic compounds carrying a substituted cycloaliphatic radical and use thereof for treating vasopressin-related diseases
ABBVIE DEUTSCHLAND0 citations40